KLK3 and neoplasm: Herein, we have shown that conjugation methodology of hu5A10 had an impact on the in vitro properties; i.e., both FcRn and PSA binding, of the immunoconjugates, as well as the in vivo distribution of hu5A10, tumor distribution, and therapy efficacy.